Mono(ADP-ribosyl)ation and poly(ADP-ribosyl)ation of proteins in developing liver and in hepatomas: relation of conjugate subfractions to metabolic competence and proliferation rates. 1981

R Bredehorst, and K Wielckens, and P Adamietz, and E Steinhagen-Thiessen, and H Hilz

Endogenous levels of mono(ADP-ribose)-protein conjugates are low in fetal liver. They increase during development reaching 30-times higher levels in the adult stage. Undifferentiated hepatomas also exhibit low degrees of mono(ADP-ribosyl)ation compared with differentiated tumors. The observed changes cannot be explained by depolymerisation of pre-existing protein-bound poly(ADP-ribose) groups or elongation of monomeric ADP-ribose residues since the monomeric and polymeric residues change independently, the absolute levels of residues present in the form of polymers being 20--350-times lower than monomeric ADP-ribose residues. Subfractionation of the mono(ADP-ribose)-protein conjugates on the basis of their NH2OH sensitivity also showed independent changes during liver development. The level of the NH2OH-sensitive conjugates exhibit an inverse relationship to cell proliferation rates in normal and malignant hepatic tissues, while the NH2OH-resistant subfraction, which was hardly detectable in fetal liver, could be related to the degree of terminal differentiation (relative to adult liver). The ratio of NH2OH-resistant to NH2OH-sensitive mono(ADP-ribose)-protein conjugates being near unity in adult liver, fell to extremely low values in fetal and neonatal liver. In undifferentiated hepatomas (proliferating or stationary), however, the ratio was higher than in the adult normal tissue. This parameter, then, allows one to discriminate between malignant and normal hepatic tissues with similar proliferative capacity and similar metabolic competence. On the basis of the findings presented it is suggested that covalent modification of proteins by mono(ADP-ribosyl)ation and poly(ADP-ribosyl)ation serve multiple and independent functions.

UI MeSH Term Description Entries
D008099 Liver A large lobed glandular organ in the abdomen of vertebrates that is responsible for detoxification, metabolism, synthesis and storage of various substances. Livers
D008114 Liver Neoplasms, Experimental Experimentally induced tumors of the LIVER. Hepatoma, Experimental,Hepatoma, Morris,Hepatoma, Novikoff,Experimental Hepatoma,Experimental Hepatomas,Experimental Liver Neoplasms,Hepatomas, Experimental,Neoplasms, Experimental Liver,Experimental Liver Neoplasm,Liver Neoplasm, Experimental,Morris Hepatoma,Novikoff Hepatoma
D009363 Neoplasm Proteins Proteins whose abnormal expression (gain or loss) are associated with the development, growth, or progression of NEOPLASMS. Some neoplasm proteins are tumor antigens (ANTIGENS, NEOPLASM), i.e. they induce an immune reaction to their tumor. Many neoplasm proteins have been characterized and are used as tumor markers (BIOMARKERS, TUMOR) when they are detectable in cells and body fluids as monitors for the presence or growth of tumors. Abnormal expression of ONCOGENE PROTEINS is involved in neoplastic transformation, whereas the loss of expression of TUMOR SUPPRESSOR PROTEINS is involved with the loss of growth control and progression of the neoplasm. Proteins, Neoplasm
D009702 Nucleoside Diphosphate Sugars Diphosphate Sugars, Nucleoside,Sugars, Nucleoside Diphosphate
D011064 Poly Adenosine Diphosphate Ribose A polynucleotide formed from the ADP-RIBOSE moiety of nicotinamide-adenine dinucleotide (NAD) by POLY(ADP-RIBOSE) POLYMERASES. Poly ADP Ribose,Poly(ADP-Ribose),Poly-ADPR,Poly-Adenosine Diphosphate-Ribose,ADP Ribose, Poly,Diphosphate-Ribose, Poly-Adenosine,Poly ADPR,Ribose, Poly ADP
D011506 Proteins Linear POLYPEPTIDES that are synthesized on RIBOSOMES and may be further modified, crosslinked, cleaved, or assembled into complex proteins with several subunits. The specific sequence of AMINO ACIDS determines the shape the polypeptide will take, during PROTEIN FOLDING, and the function of the protein. Gene Products, Protein,Gene Proteins,Protein,Protein Gene Products,Proteins, Gene
D002454 Cell Differentiation Progressive restriction of the developmental potential and increasing specialization of function that leads to the formation of specialized cells, tissues, and organs. Differentiation, Cell,Cell Differentiations,Differentiations, Cell
D002455 Cell Division The fission of a CELL. It includes CYTOKINESIS, when the CYTOPLASM of a cell is divided, and CELL NUCLEUS DIVISION. M Phase,Cell Division Phase,Cell Divisions,Division Phase, Cell,Division, Cell,Divisions, Cell,M Phases,Phase, Cell Division,Phase, M,Phases, M
D005333 Fetus The unborn young of a viviparous mammal, in the postembryonic period, after the major structures have been outlined. In humans, the unborn young from the end of the eighth week after CONCEPTION until BIRTH, as distinguished from the earlier EMBRYO, MAMMALIAN. Fetal Structures,Fetal Tissue,Fetuses,Mummified Fetus,Retained Fetus,Fetal Structure,Fetal Tissues,Fetus, Mummified,Fetus, Retained,Structure, Fetal,Structures, Fetal,Tissue, Fetal,Tissues, Fetal
D006878 Hydroxides Inorganic compounds that contain the OH- group.

Related Publications

R Bredehorst, and K Wielckens, and P Adamietz, and E Steinhagen-Thiessen, and H Hilz
January 1992, Journal of nutritional science and vitaminology,
R Bredehorst, and K Wielckens, and P Adamietz, and E Steinhagen-Thiessen, and H Hilz
May 1983, Biochemical and biophysical research communications,
R Bredehorst, and K Wielckens, and P Adamietz, and E Steinhagen-Thiessen, and H Hilz
December 1991, Biochemical and biophysical research communications,
R Bredehorst, and K Wielckens, and P Adamietz, and E Steinhagen-Thiessen, and H Hilz
April 2005, Cellular and molecular life sciences : CMLS,
R Bredehorst, and K Wielckens, and P Adamietz, and E Steinhagen-Thiessen, and H Hilz
January 2004, Experimental gerontology,
R Bredehorst, and K Wielckens, and P Adamietz, and E Steinhagen-Thiessen, and H Hilz
July 2005, Pharmacological research,
R Bredehorst, and K Wielckens, and P Adamietz, and E Steinhagen-Thiessen, and H Hilz
December 2013, Molecular aspects of medicine,
R Bredehorst, and K Wielckens, and P Adamietz, and E Steinhagen-Thiessen, and H Hilz
July 2011, Trends in plant science,
R Bredehorst, and K Wielckens, and P Adamietz, and E Steinhagen-Thiessen, and H Hilz
December 2013, Molecular aspects of medicine,
R Bredehorst, and K Wielckens, and P Adamietz, and E Steinhagen-Thiessen, and H Hilz
January 1984, Methods in enzymology,
Copied contents to your clipboard!